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It is our great pleasure to introduce this Special Issue entitled “Toxicology and Bio-
compatibility of Nanomaterials”. As the understanding of materials at the nanoscale and
the ability to control their structure improves, a wide range of nanomaterials (NMs) with
novel characteristics and applications are being fabricated for electronics, engineering, and,
more recently, biomedical research applications. Although the technological and economic
benefits of NMs are obvious, concern has also been raised that the very same properties,
which enable a variety of novel applications, might have adverse effects if such a material
is inhaled, ingested, applied to the skin or even released into the environment [1]. These
concerns have led to an increasing discussion worldwide about possible regulatory policies
for NMs. Therefore, there is a clear need to establish convincing scientific knowledge to
assess the impact of NMs on human health and the ecosystem. These questions can only
be tackled by collaborative research at the interface of engineering, physics, chemistry,
toxicology and biology, as outlined in our first Special Issue on the topic one decade ago [2].
Meanwhile, the field of nanotoxicology has come of age, and is an established discipline
in toxicology.
This Special Issue comprises six research articles and two timely reviews and covers
research in the field of nanotoxicology, with a particular interest in molecular mechanism
of action as well as the safe-by-design concept, i.e., the synthesis of biocompatible nano-
materials. Additionally, the impact of the biomolecular corona, which is the interaction of
biomolecules with the NM surface, on toxicity and biocompatibility, is addressed.
The first study addresses the effects of ZnO NMs on blood glucose levels in healthy
and diabetic rats and discusses potential clinical applications [3]. The following articles
are mainly in vitro studies with a focus on mechanisms of NM toxicity. Macrophages
are important targets of NMs; therefore, the understanding of molecular initiating events
is of high relevance. A series of TiO2 NMs with different characteristics were studied
in rat alveolar macrophages and activation of the NLRP3 inflammasome is presented,
highlighting the importance of case-to-case studies for proper hazard assessment [4]. In
murine macrophages, the poorly understood mixture effects of co-pollutants and NMs
has been investigated [5]. The authors demonstrate synergistic activities of silica NMs
and genotoxic agents, thus reinforcing the notion that there is an urgent need to pay
more attention to mixture effects in the future. Apart from the innate immune system,
the gastrointestinal tract is an important target tissue. Therefore, the toxicity of silica
NMs is explored in gastrointestinal cells [6], specifically in the presence or absence of
serum, because the biomolecular corona has previously been shown to critically determine
detrimental effects in other cell types [7]. Although in the presence of serum even pro-
proliferative effects have been shown in gastric cells [8], in the absence of serum, silica
NMs potently induce cell death in colon carcinoma cells; however, this is independent of
the key regulators p53 and BAX, suggesting the potential for their further development
as anticancer nanodrugs [6]. Although the field of nanotoxicology has matured and
solved most of the initial technical problems and challenges, there are still issues which
hamper proper hazard assessment. These include, but are not limited to, the reproducible
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synthesis of NMs with clearly characterized physico-chemical properties [9], as well as the
establishment of more physiologically relevant test systems [10] and standard operating
procedures for toxicity testing to provide comparable results across laboratories. Thus,
fifteen European laboratories performed an inter-laboratory comparison to assess the
toxicity of polystyrene NMs with the widely used MTS assay and provide guidance on
how to improve reliable testing [11]. Finally, the interactions of CeO2 and TiO2 NMs and
algae were addressed in an ecotoxicity study, and the importance of the adherence of NMs
to the test organism was identified as an important parameter to predict toxicity [12].
Two reviews conclude this Special Issue. The first summarizes our knowledge of
airborne NMs and their potential adverse effects on the nervous system with a specific
focus on neurodegenerative diseases [13]. The final contribution provides a fresh outlook
on positive aspects of NM actions in biological systems, i.e., their use in medicine as tools
to diagnose and treat cancer [14].
In conclusion, we would like to thank all the authors for their interesting and excellent
contributions, and the many constructive reviewers and the editorial team who helped
to bring this Special Issue to fruition. We hope that a broad readership will enjoy this
Special Issue.
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